BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 15126362)

  • 1. Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions.
    Ohuchida K; Mizumoto K; Murakami M; Qian LW; Sato N; Nagai E; Matsumoto K; Nakamura T; Tanaka M
    Cancer Res; 2004 May; 64(9):3215-22. PubMed ID: 15126362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-stromal cell interaction under hypoxia increases the invasiveness of pancreatic cancer cells through the hepatocyte growth factor/c-Met pathway.
    Ide T; Kitajima Y; Miyoshi A; Ohtsuka T; Mitsuno M; Ohtaka K; Koga Y; Miyazaki K
    Int J Cancer; 2006 Dec; 119(12):2750-9. PubMed ID: 16998831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation stimulates HGF receptor/c-Met expression that leads to amplifying cellular response to HGF stimulation via upregulated receptor tyrosine phosphorylation and MAP kinase activity in pancreatic cancer cells.
    Qian LW; Mizumoto K; Inadome N; Nagai E; Sato N; Matsumoto K; Nakamura T; Tanaka M
    Int J Cancer; 2003 May; 104(5):542-9. PubMed ID: 12594808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-cultivation of pancreatic cancer cells with orthotopic tumor-derived fibroblasts: fibroblasts stimulate tumor cell invasion via HGF secretion whereas cancer cells exert a minor regulative effect on fibroblasts HGF production.
    Qian LW; Mizumoto K; Maehara N; Ohuchida K; Inadome N; Saimura M; Nagai E; Matsumoto K; Nakamura T; Tanaka M
    Cancer Lett; 2003 Feb; 190(1):105-12. PubMed ID: 12536083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions.
    Nakamura T; Matsumoto K; Kiritoshi A; Tano Y; Nakamura T
    Cancer Res; 1997 Aug; 57(15):3305-13. PubMed ID: 9242465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cells.
    Maehara N; Matsumoto K; Kuba K; Mizumoto K; Tanaka M; Nakamura T
    Br J Cancer; 2001 Mar; 84(6):864-73. PubMed ID: 11259105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of growth, invasion, and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model.
    Tomioka D; Maehara N; Kuba K; Mizumoto K; Tanaka M; Matsumoto K; Nakamura T
    Cancer Res; 2001 Oct; 61(20):7518-24. PubMed ID: 11606388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of transferred NK4 gene on biological characteristics of human pancreatic cancer cell line SW1990].
    Lai RX; Yuan SZ; Nakamura T
    Ai Zheng; 2004 Oct; 23(10):1134-8. PubMed ID: 15473922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist.
    Martin TA; Parr C; Davies G; Watkins G; Lane J; Matsumoto K; Nakamura T; Mansel RE; Jiang WG
    Carcinogenesis; 2003 Aug; 24(8):1317-23. PubMed ID: 12807719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
    Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced HGF expression in subcutaneous CT26 tumor genetically modified to secrete NK4 and its possible relation with antitumor effects.
    Kubota T; Fujiwara H; Amaike H; Takashima K; Inada S; Atsuji K; Yoshimura M; Matsumoto K; Nakamura T; Yamagishi H
    Cancer Sci; 2004 Apr; 95(4):321-7. PubMed ID: 15072590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
    De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
    J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1.
    Matsushita A; Götze T; Korc M
    Cancer Res; 2007 Nov; 67(21):10309-16. PubMed ID: 17974973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion.
    Cheng N; Chytil A; Shyr Y; Joly A; Moses HL
    Mol Cancer Res; 2008 Oct; 6(10):1521-33. PubMed ID: 18922968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene transduction of NK4, HGF antagonist, inhibits in vitro invasion and in vivo growth of human pancreatic cancer.
    Maehara N; Nagai E; Mizumoto K; Sato N; Matsumoto K; Nakamura T; Narumi K; Nukiwa T; Tanaka M
    Clin Exp Metastasis; 2002; 19(5):417-26. PubMed ID: 12198770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer cell-derived IL-1α promotes HGF secretion by stromal cells and enhances metastatic potential in pancreatic cancer cells.
    Xu D; Matsuo Y; Ma J; Koide S; Ochi N; Yasuda A; Funahashi H; Okada Y; Takeyama H
    J Surg Oncol; 2010 Oct; 102(5):469-77. PubMed ID: 20872950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling of tumor-stromal interactions between pancreatic cancer cells and stromal fibroblasts.
    Sato N; Maehara N; Goggins M
    Cancer Res; 2004 Oct; 64(19):6950-6. PubMed ID: 15466186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast hepatocyte growth factor promotes invasion of human mammary ductal carcinoma in situ.
    Jedeszko C; Victor BC; Podgorski I; Sloane BF
    Cancer Res; 2009 Dec; 69(23):9148-55. PubMed ID: 19920187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ.
    Casbas-Hernandez P; D'Arcy M; Roman-Perez E; Brauer HA; McNaughton K; Miller SM; Chhetri RK; Oldenburg AL; Fleming JM; Amos KD; Makowski L; Troester MA
    Breast Cancer Res; 2013; 15(5):R82. PubMed ID: 24025166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor.
    Date K; Matsumoto K; Kuba K; Shimura H; Tanaka M; Nakamura T
    Oncogene; 1998 Dec; 17(23):3045-54. PubMed ID: 9881707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.